Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study

[1]  H. Onishi,et al.  The minimum required interval between hydrogel spacer injection and treatment planning for stereotactic body radiotherapy for prostate cancer. , 2022, Practical Radiation Oncology.

[2]  M. Pinkawa,et al.  SpaceOAR Hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review. , 2021, Urology.

[3]  R. Smeenk,et al.  Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer , 2021, Clinical and translational radiation oncology.

[4]  A. Rostami,et al.  Effectiveness of rectal displacement devices during prostate external-beam radiation therapy: A review , 2021, Journal of Cancer Research and Therapeutics.

[5]  J. Efstathiou,et al.  Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate Cancer , 2020, JAMA network open.

[6]  J. Westhuyzen,et al.  Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertion , 2019, Journal of medical imaging and radiation oncology.

[7]  L. Beckman,et al.  Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial , 2019, The Lancet.

[8]  A. Louie,et al.  Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy. , 2019, Practical radiation oncology.

[9]  C. Elliston,et al.  A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy , 2018, Radiation Oncology.

[10]  Zhongjie Lu,et al.  The role of radioprotective spacers in clinical practice: a review. , 2018, Quantitative Imaging in Medicine and Surgery.

[11]  P. Lambin,et al.  Dynamics of rectal balloon implant shrinkage in prostate VMAT , 2017, Strahlentherapie und Onkologie.

[12]  M. Eble,et al.  Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results. , 2017, International journal of radiation oncology, biology, physics.

[13]  Hiram Gay,et al.  Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. , 2017, International journal of radiation oncology, biology, physics.

[14]  T. Eade,et al.  SpaceOAR Hydrogel in Dose-escalated Prostate Cancer Radiotherapy: Rectal Dosimetry and Late Toxicity. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[15]  P. Lambin,et al.  Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Y. Lotan,et al.  Decision analysis model evaluating the cost of a temporary hydrogel rectal spacer before prostate radiation therapy to reduce the incidence of rectal complications. , 2016, Urologic oncology.

[17]  J. Jonsson,et al.  EP-1533: ICE-Studio - An Interactive visual research tool for image analysis , 2015 .

[18]  E. Decullier,et al.  Prostate hypofractionated radiation therapy with injection of hyaluronic acid: acute toxicities in a phase 2 study. , 2015, International journal of radiation oncology, biology, physics.

[19]  P. Lambin,et al.  Spacers in radiotherapy treatment of prostate cancer: is reduction of toxicity cost-effective? , 2015, Radiotherapy and Oncology.

[20]  Guangjun Li,et al.  High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up , 2015, Journal of Cancer Research and Clinical Oncology.

[21]  J. Vaňásek,et al.  Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer , 2015, Strahlentherapie und Onkologie.

[22]  K. Herfarth,et al.  Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial , 2014, Radiation oncology.

[23]  M. Colombel,et al.  Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy. , 2014, International journal of radiation oncology, biology, physics.

[24]  P. Fransson,et al.  Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects , 2001, Supportive Care in Cancer.

[25]  K. Herfarth,et al.  A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. , 2013, International journal of radiation oncology, biology, physics.

[26]  P. Stattin,et al.  Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. , 2013, International journal of epidemiology.

[27]  M. Anscher,et al.  Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  M. Eble,et al.  Spacer stability and prostate position variability during radiotherapy for prostate cancer applying a hydrogel to protect the rectal wall. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  R. Smeenk,et al.  Impact of late anorectal dysfunction on quality of life after pelvic radiotherapy , 2013, International Journal of Colorectal Disease.

[30]  C. Hosford,et al.  Human collagen injections to reduce rectal dose during radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[31]  K. Thursky,et al.  Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy. , 2012, The British journal of radiology.

[32]  S. Fosså,et al.  Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity. , 2010, International journal of radiation oncology, biology, physics.

[33]  D. Bradley,et al.  Viscosity changes in hyaluronic acid: irradiation and rheological studies. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[34]  R. C. Susil,et al.  Effects of prostate-rectum separation on rectal dose from external beam radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[35]  Max A. Viergever,et al.  elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.

[36]  Fredrik Wiklund,et al.  Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial. , 2009, The Lancet. Oncology.

[37]  Y. Yamada,et al.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[38]  J Alfred Witjes,et al.  Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. , 2007, International journal of radiation oncology, biology, physics.

[39]  P. Prada,et al.  Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients. , 2007, International journal of radiation oncology, biology, physics.

[40]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[41]  J. Denham,et al.  Is there more than one late radiation proctitis syndrome? , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[43]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.